Cargando…

Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis

OBJECTIVE: To elucidate the pathogenesis of dupilumab (Dupixent®)–associated ocular surface disease (DAOSD). DESIGN: Prospective single-center cohort study. SUBJECTS: Twenty patients with moderate-to-severe atopic dermatitis (AD) who received dupilumab and 10 age- and sex-matched healthy controls we...

Descripción completa

Detalles Bibliográficos
Autores principales: Patra, VijayKumar, Woltsche, Nora, Cerpes, Urban, Bokanovic, Danijela, Repelnig, Maria, Joshi, Aaroh, Perchthaler, Isabella, Fischl, Manuela, Vocanson, Marc, Bordag, Natalie, Durdevic, Marija, Woltsche, Johannes, Quehenberger, Franz, Legat, Franz, Wedrich, Andreas, Horwath-Winter, Jutta, Wolf, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585475/
https://www.ncbi.nlm.nih.gov/pubmed/37869024
http://dx.doi.org/10.1016/j.xops.2023.100340
_version_ 1785122964444807168
author Patra, VijayKumar
Woltsche, Nora
Cerpes, Urban
Bokanovic, Danijela
Repelnig, Maria
Joshi, Aaroh
Perchthaler, Isabella
Fischl, Manuela
Vocanson, Marc
Bordag, Natalie
Durdevic, Marija
Woltsche, Johannes
Quehenberger, Franz
Legat, Franz
Wedrich, Andreas
Horwath-Winter, Jutta
Wolf, Peter
author_facet Patra, VijayKumar
Woltsche, Nora
Cerpes, Urban
Bokanovic, Danijela
Repelnig, Maria
Joshi, Aaroh
Perchthaler, Isabella
Fischl, Manuela
Vocanson, Marc
Bordag, Natalie
Durdevic, Marija
Woltsche, Johannes
Quehenberger, Franz
Legat, Franz
Wedrich, Andreas
Horwath-Winter, Jutta
Wolf, Peter
author_sort Patra, VijayKumar
collection PubMed
description OBJECTIVE: To elucidate the pathogenesis of dupilumab (Dupixent®)–associated ocular surface disease (DAOSD). DESIGN: Prospective single-center cohort study. SUBJECTS: Twenty patients with moderate-to-severe atopic dermatitis (AD) who received dupilumab and 10 age- and sex-matched healthy controls were enrolled in the study. METHODS: The study cohort underwent a thorough slit-lamp and entire-body dermatologic examination. Conjunctival swabs and smears were collected at baseline, 4 and 16 weeks after treatment initiation, and during the conjunctivitis episode. To analyse the ocular surface microbiome, 16S ribosomal RNA sequencing was performed, smears were hematoxylin and eosin stained, and serum cytokines were measured by using a multiplex immunobead assay. MAIN OUTCOME MEASURES: Composition of ocular surface microbiome and cellular component as well as serum cytokine levels. RESULTS: Six of the 20 patients with AD developed DAOSD after dupilumab initiation; these patients responded after a delay to treatment as quantified by Eczema Area and Severity Index and Investigator’s Global Assessment score. Conjunctival smears showed massive neutrophilic infiltration and serum analysis revealed increased systemic levels of neutrophil-priming proinflammatory cytokines, in particular interleukin-1β and tumor necrosis factor α, in patients with DAOSD compared with those without it. The ocular surface microbiome of patients with DAOSD was characterized by a diverse and persistent microbial colonization, particularly by Acetobacter aceti. In contrast, microbial diversity decreased in patients with AD without DAOSD after the initiation of dupilumab treatment, especially the abundance of Staphylococcus aureus. In vitro experiments substantiated the potential role of the microbiome, showing increased growth of A. aceti and decreased growth of S. aureus in presence of dupilumab. CONCLUSIONS: Persistent neutrophilic infiltration and a unique microbial landscape on the ocular surface associated with elevated levels of systemic proinflammatory cytokines typify DAOSD. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
format Online
Article
Text
id pubmed-10585475
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105854752023-10-20 Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis Patra, VijayKumar Woltsche, Nora Cerpes, Urban Bokanovic, Danijela Repelnig, Maria Joshi, Aaroh Perchthaler, Isabella Fischl, Manuela Vocanson, Marc Bordag, Natalie Durdevic, Marija Woltsche, Johannes Quehenberger, Franz Legat, Franz Wedrich, Andreas Horwath-Winter, Jutta Wolf, Peter Ophthalmol Sci Original Articles OBJECTIVE: To elucidate the pathogenesis of dupilumab (Dupixent®)–associated ocular surface disease (DAOSD). DESIGN: Prospective single-center cohort study. SUBJECTS: Twenty patients with moderate-to-severe atopic dermatitis (AD) who received dupilumab and 10 age- and sex-matched healthy controls were enrolled in the study. METHODS: The study cohort underwent a thorough slit-lamp and entire-body dermatologic examination. Conjunctival swabs and smears were collected at baseline, 4 and 16 weeks after treatment initiation, and during the conjunctivitis episode. To analyse the ocular surface microbiome, 16S ribosomal RNA sequencing was performed, smears were hematoxylin and eosin stained, and serum cytokines were measured by using a multiplex immunobead assay. MAIN OUTCOME MEASURES: Composition of ocular surface microbiome and cellular component as well as serum cytokine levels. RESULTS: Six of the 20 patients with AD developed DAOSD after dupilumab initiation; these patients responded after a delay to treatment as quantified by Eczema Area and Severity Index and Investigator’s Global Assessment score. Conjunctival smears showed massive neutrophilic infiltration and serum analysis revealed increased systemic levels of neutrophil-priming proinflammatory cytokines, in particular interleukin-1β and tumor necrosis factor α, in patients with DAOSD compared with those without it. The ocular surface microbiome of patients with DAOSD was characterized by a diverse and persistent microbial colonization, particularly by Acetobacter aceti. In contrast, microbial diversity decreased in patients with AD without DAOSD after the initiation of dupilumab treatment, especially the abundance of Staphylococcus aureus. In vitro experiments substantiated the potential role of the microbiome, showing increased growth of A. aceti and decreased growth of S. aureus in presence of dupilumab. CONCLUSIONS: Persistent neutrophilic infiltration and a unique microbial landscape on the ocular surface associated with elevated levels of systemic proinflammatory cytokines typify DAOSD. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references. Elsevier 2023-05-29 /pmc/articles/PMC10585475/ /pubmed/37869024 http://dx.doi.org/10.1016/j.xops.2023.100340 Text en © 2023 by the American Academy of Ophthalmology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Articles
Patra, VijayKumar
Woltsche, Nora
Cerpes, Urban
Bokanovic, Danijela
Repelnig, Maria
Joshi, Aaroh
Perchthaler, Isabella
Fischl, Manuela
Vocanson, Marc
Bordag, Natalie
Durdevic, Marija
Woltsche, Johannes
Quehenberger, Franz
Legat, Franz
Wedrich, Andreas
Horwath-Winter, Jutta
Wolf, Peter
Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis
title Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis
title_full Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis
title_fullStr Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis
title_full_unstemmed Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis
title_short Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis
title_sort persistent neutrophil infiltration and unique ocular surface microbiome typify dupilumab–associated conjunctivitis in patients with atopic dermatitis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585475/
https://www.ncbi.nlm.nih.gov/pubmed/37869024
http://dx.doi.org/10.1016/j.xops.2023.100340
work_keys_str_mv AT patravijaykumar persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT woltschenora persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT cerpesurban persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT bokanovicdanijela persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT repelnigmaria persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT joshiaaroh persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT perchthalerisabella persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT fischlmanuela persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT vocansonmarc persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT bordagnatalie persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT durdevicmarija persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT woltschejohannes persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT quehenbergerfranz persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT legatfranz persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT wedrichandreas persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT horwathwinterjutta persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis
AT wolfpeter persistentneutrophilinfiltrationanduniqueocularsurfacemicrobiometypifydupilumabassociatedconjunctivitisinpatientswithatopicdermatitis